At a glance
ClinicalIndex Comparison RecordN/ACompleted· 547 enrolled
Drug / intervention
Inhaled corticosteroids +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Asthma Control Evaluation (ACE): A Biomarker-Based Approach to Improving Asthma Control and Mechanistic Studies (DAIT ICAC-02)
National Institute of Allergy and Infectious Diseases (NIAID)·interventional·Posted Jun 15, 2005·Updated Feb 10, 2017
In Brief
A clinical study evaluating Inhaled corticosteroids and eNO measurement for Asthma. Completed, enrolled 547 participants across 12 sites.
Detailed Summary
The purpose of ICAC-01 is to determine whether an asthma treatment strategy that measures exhaled nitric oxide (eNO) to indicate disease progression is more effective in treating asthma symptoms when combined with existing asthma treatment guidelines than treatment using the guidelines alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2004
First PostedJun 2005
Primary CompletionNov 2006
TodayJul 2026
First PostedJun 15, 2005
Enrollment StartAug 1, 2004
Primary CompletionNov 1, 2006
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 21.0 years ago
Interventions
Inhaled corticosteroidsdrug
Used for both regular asthma control and as a rescue inhaler
eNO measurementprocedure
measured by Aerocrine® NIOX device